Literature DB >> 2911679

Head and neck lesions: MR-guided aspiration biopsy.

G Duckwiler1, R B Lufkin, L Teresi, E Spickler, J Dion, F Viñuela, J Bentson, W Hanafee.   

Abstract

Aspiration biopsy guided with computed tomography (CT) has long been a valuable tool in the evaluation of head and neck disease. The ability to obtain diagnoses without the need for surgery has had a significant effect on patient treatment. Magnetic resonance (MR) imaging is now rapidly replacing CT as the primary imaging study for many head and neck diseases. The standard stainless steel needles used for CT-guided biopsy are unsuitable for MR-guided biopsy because significant ferromagnetic artifacts obscure the underlying anatomy. A new needle has recently been designed specifically for use with MR imaging. This needle has far less magnetic susceptibility and therefore does not cause significant image distortion. The authors describe the use of this needle in MR-guided aspiration biopsy of a variety of lesions in the head and neck.

Entities:  

Mesh:

Year:  1989        PMID: 2911679     DOI: 10.1148/radiology.170.2.2911679

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  MRI-guided biopsy and aspiration in the head and neck: evaluation of 77 patients.

Authors:  Yubo Lü; Ming Liu; Chengli Li; Lebin Wu; Jan Fritz
Journal:  Eur Radiol       Date:  2011-10-11       Impact factor: 5.315

2.  Magnetic resonance imaging-guided fine needle aspiration for the diagnosis of skull base lesions.

Authors:  R Wenokur; J C Andrews; E Abemayor; J Bailet; L Layfield; R F Canalis; B Jabour; R B Lufkin
Journal:  Skull Base Surg       Date:  1992

3.  CT-guided aspirations in the head and neck: assessment of the first 216 cases.

Authors:  Paul M Sherman; David M Yousem; Laurie A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

4.  Visualization of magnetic resonance-compatible needles at 1.5 and 0.2 Tesla.

Authors:  C Frahm; H B Gehl; U H Melchert; H D Weiss
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Sep-Oct       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.